Product Images Pentasa

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Pentasa NDC 54092-191 by Takeda Pharmaceuticals America, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pentasa 01

pentasa 01

PRINCIPAL DISPLAY PANEL - 250 mg Capsule Bottle Label - pentasa 02

PRINCIPAL DISPLAY PANEL - 250 mg Capsule Bottle Label - pentasa 02

Pentasa is an extended-release capsule distributed by Takeda Pharmaceuticals. This medication is a trademark of ervring BV used under license. The information contained in the text is limited and does not provide extensive detail other than the information on the medication and its distributor.*

PRINCIPAL DISPLAY PANEL - 500 mg Capsule Bottle Label - pentasa 03

PRINCIPAL DISPLAY PANEL - 500 mg Capsule Bottle Label - pentasa 03

PRINCIPAL DISPLAY PANEL - 500 mg Capsule Sample Carton - pentasa 04

PRINCIPAL DISPLAY PANEL - 500 mg Capsule Sample Carton - pentasa 04

Pentasa® (mesalamine) is a medicine that comes in the form of Controlled-Release Capsules. The Dosage and Administration of the medicine are written on the package insert, making the drug useful for curing many ailments. However, the label warns that the medicine should be kept out of the reach of children and should be stored at 25°C (50-85°F). The other information about the medicine is not available.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.